Preclinical models derived from endoscopic ultrasound-guided tissue acquisition for individualized treatment of pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with poor outcomes. Although the management strategies have evolved in recent years, the PDAC 5-year survival rate remains at only 9%; it may become the second leading cause of cancer death in the USA by 2030. Only 15–20% of PDAC pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Ting, Zhang, Chao, Li, Jingbo, Deng, Minzi, Wang, Xiaoyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849774/
https://www.ncbi.nlm.nih.gov/pubmed/36687406
http://dx.doi.org/10.3389/fmed.2022.934974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849774/
https://www.ncbi.nlm.nih.gov/pubmed/36687406
http://dx.doi.org/10.3389/fmed.2022.934974

Ejemplares similares